ROYAL BANK OF CANADA - PDS BIOTECHNOLOGY CORP ownership

PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 67 filers reported holding PDS BIOTECHNOLOGY CORP in Q4 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of PDS BIOTECHNOLOGY CORP
ValueSharesWeighting
Q3 2023$30,000
+200.0%
5,835
+194.1%
0.00%
Q2 2023$10,000
+400.0%
1,984
+693.6%
0.00%
Q1 2023$2,000
-33.3%
2500.0%0.00%
Q4 2022$3,000
+200.0%
250
-0.8%
0.00%
Q3 2022$1,0000.0%252
+0.8%
0.00%
Q2 2022$1,000
-88.9%
250
-82.4%
0.00%
Q1 2022$9,000
+125.0%
1,422
+181.6%
0.00%
Q4 2021$4,000
-77.8%
505
-87.4%
0.00%
Q1 2021$18,000
+800.0%
4,000
+1011.1%
0.00%
Q2 2019$2,0003600.00%
Other shareholders
PDS BIOTECHNOLOGY CORP shareholders Q4 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,499,149$18,814,0003.39%
New Leaf Venture Partners, L.L.C. 117,242$7,975,0002.05%
Worth Venture Partners, LLC 348,703$4,376,0001.63%
INSPIRION WEALTH ADVISORS, LLC 253,262$3,178,0000.78%
EAM Global Investors LLC 187,900$2,358,0000.65%
EAM Investors, LLC 279,613$3,509,0000.54%
ACT CAPITAL MANAGEMENT, LLC 45,000$565,0000.29%
Andesa Financial Management Inc. 33,310$418,0000.13%
Monashee Investment Management LLC 80,000$1,004,0000.12%
Sofinnova Investments, Inc. 142,635$1,790,0000.10%
View complete list of PDS BIOTECHNOLOGY CORP shareholders